Schedule 13G ownership disclosure

Kura Oncology Inc

Common Stock, $0.0001 par value per share · CUSIP: 50127T109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Paradigm BioCapital Advisors LP

    Shares: 0.00 · Class: 0.0%

  • Paradigm BioCapital Advisors GP LLC

    Shares: 0.00 · Class: 0.0%

  • Senai Asefaw, M.D.

    Shares: 0.00 · Class: 0.0%

  • Paradigm BioCapital International Fund Ltd.

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014236
Form type
SCHEDULE 13G/A
Filer
Kura Oncology, Inc.
CIK
CIK 1422143
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub